Masakazu Hatano

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Systematic Review

Hyaluronic Acid

Major Depressive Disorder

Electronic Health Record

Top Venues

Psychiatry and clinical neurosciences

Neuropsychiatric disease and treatment

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Human psychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Masakazu Hatano, Haruna Matsuzaki, Takeo Saito, Shigeki Yamada
A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative Analysis. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 22 (3) (2024)
Masakazu Hatano, Haruna Matsuzaki, Takeo Saito, Shigeki Yamada
A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative Analysis. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 22 (3) (2024)
Masakazu Hatano, Haruna Matsuzaki, Takeo Saito, Shigeki Yamada
A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative Analysis. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 22 (3) (2024)
Masakazu Hatano, Kaho Yamada, Haruna Matsuzaki, Rina Yokoi, Takeo Saito, Shigeki Yamada
Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database. PloS one 18 (6) (2023)
Haruna Matsuzaki, Masakazu Hatano, Miko Iwata, Takeo Saito, Shigeki Yamada
Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study. Neuropsychiatric disease and treatment 19 (2023)
Miko Iwata, Masakazu Hatano, Kana Ito, Haruna Matsuzaki, Shigeki Yamada
Clinical Laboratory Data in Japan: A Comparative Study of Patients with Psychiatric Disorders and the General Population. Neuropsychiatric disease and treatment 19 (2023)
Taro Kishi, Toshikazu Ikuta, Kenji Sakuma, Masakazu Hatano, Yuki Matsuda, Satoru Esumi, Nobumi Miyake, Itaru Miura, Masaki Kato, Nakao Iwata
Safety profile of antidepressant for Japanese adults with major depressive disorder: a systematic review and network meta-analysis. Psychiatry and clinical neurosciences (2023)
Masakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, Kazuhiko Gomi, Takashi Sakakibara, Shogo Hotta, Satoru Esumi, Kiyotaka Tsubouchi, Yoshihito Shimizu, Shigeki Yamada
Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study. BMC psychiatry 23 (1) (2023)
Kenji Sakuma, Taro Kishi, Shohei Sanji, Ikuo Nomura, Masakazu Hatano, Makoto Okuya, Nakao Iwata
Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta-analysis. Psychiatry and clinical neurosciences (2023)
Kenji Sakuma, Taro Kishi, Shohei Sanji, Ikuo Nomura, Masakazu Hatano, Makoto Okuya, Nakao Iwata
Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta-analysis. Psychiatry and clinical neurosciences (2023)
Haruna Matsuzaki, Masakazu Hatano, Miko Iwata, Takeo Saito, Shigeki Yamada
Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study. Neuropsychiatric disease and treatment 19 (2023)
Taro Kishi, Kenji Sakuma, Masakazu Hatano, Nakao Iwata
N-acetylcysteine for schizophrenia: A systematic review and meta-analysis. Psychiatry and clinical neurosciences (2022)
Haruna Matsuzaki, Masakazu Hatano, Miko Iwata, Shigeki Yamada
Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study. Neuropsychiatric disease and treatment 17 (2021)
Taro Kishi, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, Nakao Iwata
Duration of long-acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia. Psychiatry and clinical neurosciences (2021)
Masakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, Kaori Tozawa, Shinya Makino, Manako Hanya, Shigeki Yamada, Nakao Iwata
The effects of different periods of co-administration of oral and long-acting injectable aripiprazole: A propensity score analysis. Human psychopharmacology 34 (1) (2018)